title: Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumours.
authors.affiliation: Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo.
authors.forename: A M
authors.initials: AM
authors.lastname: Hernandez
authors.forename: S D
authors.initials: SD
authors.lastname: Fosså
authors.forename: A
authors.initials: A
authors.lastname: Brøgger
authors.forename: A
authors.initials: A
authors.lastname: Kat
authors.forename: E
authors.initials: E
authors.lastname: Skovlund
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D002869:Chromosome Aberrations; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D018237:Germinoma / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D008875:Middle Aged
chemical_list: D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin